Position in MRNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,554,242
+$31,607,842 QoQ
Shares Held
479,141
+1150.5% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 777 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. MRNA ranks #20 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in MRNA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,554,242 | 479,141 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,946,400 | 38,315 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $354,173 | 12,010 | Shares | Other | 2026-02-17 | |
| 2025-03-31 | $432,421 | 15,253 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $201,157 | 3,010 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $603,606 | 5,083 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $410,362 | 3,851 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $254,292 | 2,557 | Shares | Other | 2024-02-14 | |
| 2023-06-30 | $3,661,038 | 30,132 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $44,454,038 | 289,452 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,539,402 | 309,205 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $70,286,026 | 594,385 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $183,500,395 | 1,284,567 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $235,198,635 | 1,365,370 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $131,574,338 | 518,050 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $168,602,931 | 438,089 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $161,124,140 | 685,693 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $126,667,541 | 967,297 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,806,219 | 141,727 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,349,053 | 75,605 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,732,719 | 58,133 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $296,295 | 9,893 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||